IAV NA
Loading...Anti-IAV NA Products
+ Filter
Loading...- Recombinant Human Anti-IAV NA Antibody (PABL-589)
-
- Derivation: Human
- Species Reactivity: IAV
- Type: IgG
- Application: WB, IF, FuncS
-
- Species Reactivity: Influenza A virus
- Type: Mouse IgG
- Application: ELISA
- Human Anti-IAV NA Antibody, mRNA (PABL-589-mRNA)
-
- Species Reactivity: Influenza A virus
- Recombinant Human Anti-IAV NA Antibody (clone Z2B3) (VS-0923-XY16)
-
- Species Reactivity: IAV
- Type: Human IgG
- Application: ELISA, SPR, Neut, Inhib
- Mouse Anti-IAV NA Recombinant Antibody (clone B10); Fab fragment (PABJ-0097-F(E))
-
- Species Reactivity: Influenza A virus
- Type: Mouse Fab
- Application: ELISA
- Mouse Anti-IAV NA Recombinant Antibody (clone B10); scFv Fragment (PABJ-0097-S(P))
-
- Species Reactivity: Influenza A virus
- Type: Mouse scFv
- Application: ELISA
-
- Derivation: Human
- Species Reactivity: IAV
- Type: Fab
- Application: WB, IF, FuncS
-
- Derivation: Human
- Species Reactivity: IAV
- Type: scFv
- Application: WB, IF, FuncS
- Recombinant Anti-IAV NA VHH Single Domain Antibody (NAB-929-sdAb)
-
- Species Reactivity: IAV
- Type: Llama VHH
- Application: Neut, ChiP, IP, FUNC
- Human Anti-IAV NA Vaccinal Antibody (VS-0625-XY54) (VS-0625-XY54)
-
- Species Reactivity: IAV
- Target: IAV NA
- Host Animal: Human
- Application: ELISA, SPR, Neut, Inhib
- Type: Human IgG
- Human Anti-IAV NA Vaccinal Antibody (VS-0625-XY55) (VS-0625-XY55)
-
- Species Reactivity: IAV
- Target: IAV NA
- Host Animal: Human
- Application: ELISA, BLI, Neut
- Type: Human IgG
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Influenza A viruses cause considerable morbidity and mortality annually, posing threats to public health worldwide. Monoclonal antibodies represent a viable approach for the treatment of influenza. Antibodies targeting hemagglutinin (HA) and neuraminidase (NA), the two important surface glycoproteins of influenza virus, can disrupt viral entry into host cells and block viral egress or prevent virus from budding, respectively. Earlier work defined the structure of NA and NA-fragment antigen-binding (Fab) complexes and demonstrated the protective effects of immune responses to NA.

